Tradestie Institutional Equity Comparison Engine

MYGN vs VCYT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VCYT Overall Edge

VCYT Captures Institutional Edge (2โ€“2 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Veracyte, Inc. (VCYT) driven by superior Valuation, Growth & Margin while MYGN counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, MYGN trades at 54.0x Forward P/E with -13.3% operating margin (-1.5% YoY revenue) versus VCYT at 15.3x Forward P/E and 15.0% operating margin (+15.1% YoY). In options structure, MYGN sits in SURGE (22nd %ile IV; Dealer Gamma Walls on Pro) against VCYT sits in BREAKDOWN (47th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VCYT
MYGN 54.0x vs VCYT 15.3x Fwd P/E
Growth & Margin Winner VCYT
Op Margin -13.3% vs 15.0% ยท YoY -1.5% vs +15.1%
Momentum & Technical Winner MYGN
1Y -12.3% vs -39.8% ยท 52W Pos 53% vs 5%
Options & Structure Winner MYGN
SURGE (22nd %ile IV) vs BREAKDOWN (47th %ile IV)
MYGN NASDAQ
Myriad Genetics Inc
In Vitro & In Vivo Diagnostic Substances
$5.57
-1.59% 1D
Market Cap $542.9M
1M Return +39.95%
1Y Return -12.28%
Forward P/E 54.0x
Unified AI Score
46.2 / 100 HOLD
Tech 30.0 Fund 43.0 Flow 56.0 Mom 50.0
VCYT NASDAQ
Veracyte, Inc.
Services-Medical Laboratories
$24.01
-1.32% 1D
Market Cap $2.0B
1M Return -44.32%
1Y Return -39.78%
Forward P/E 15.3x
Unified AI Score
49.1 / 100 HOLD
Tech 55.0 Fund 56.0 Flow 57.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MYGN -12.28% VCYT -39.78% Spread: +27.5 pp (MYGN Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period MYGN Revenue VCYT Revenue MYGN Op. Margin VCYT Op. Margin Margin Edge
FY2018 $740M $90M 16.4% -24.2% MYGN
FY2019 $850M $120M 0.9% -12.6% MYGN
FY2020 $560M $120M -52.0% -30.1% VCYT
FY2021 $690M $220M -27.6% -37.3% MYGN
FY2022 $680M $300M -20.7% -13.9% VCYT
FY2023 $750M $360M -34.2% -23.8% VCYT
FY2024 $840M $450M -14.7% 3.6% VCYT
FY2025 $820M $520M -47.0% 11.2% VCYT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MYGN (2) vs VCYT (8)
Institutional Metric MYGN VCYT Criterion Row Winner
Market Capitalization Scale $542.9M $2.0B Larger Scale VCYT
Trailing P/E Ratio Valuation 54.0x 15.8x Lower Multiple VCYT
Forward P/E Ratio Valuation 54.0x 15.3x Lower Multiple VCYT
Revenue Growth (YoY) Growth -1.5% +15.1% Higher Growth VCYT
Operating Margin (TTM) Profitability -13.3% 15.0% Higher Margin VCYT
Net Profit Margin Profitability -16.1% 21.8% Higher Margin VCYT
Return on Equity (ROE) Capital Efficiency -40.2% 9.4% Higher ROE VCYT
52-Week Range Position Momentum 53% ($3โ€“$8) 5% ($22โ€“$61) Stronger Trend MYGN
Beta / 30D Volatility Risk Regime 0.68ฮฒ ยท 122% Vol 3.01ฮฒ ยท 199% Vol Lower Realized Risk MYGN
Unified Institutional Score Composite Signal 46.2 / 100 (HOLD) 49.1 / 100 (HOLD) Higher Composite VCYT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MYGN vs VCYT Buy Guide
MYGN SURGE
12d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 22nd %ile
IV Regime Compressed (<25th %ile)
Live MYGN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VCYT BREAKDOWN
99d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 47th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live VCYT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MYGN nor VCYT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.